
Part 3 in a four-part series on solving the toll of depression on populations. Pim Cuijpers focuses on the psychological treatment of depression and gives an overview of a meta-analytic research domain.
[read the full story...]Part 3 in a four-part series on solving the toll of depression on populations. Pim Cuijpers focuses on the psychological treatment of depression and gives an overview of a meta-analytic research domain.
[read the full story...]Louise Arsenault provides a fascinating overview on the challenges and complexities of sharing mental health data in the UK.
[read the full story...]Jessica Scaife reviews a individual patient data meta-analysis exploring the continuation of antidepressants versus sequential psychological interventions to prevent relapse in depression.
[read the full story...]Joe Hayes summarises a new meta-analysis in the British Journal of Psychiatry that shows how the initial severity of depression does not alter the efficacy of cognitive behavioural therapy.
This is the first in a new series of Mental Elf blogs produced in partnership with the British Journal of Psychiatry.
[read the full story...]Stefan Rennick-Egglestone highlights a brand new IPD meta-analysis of self-guided Internet-based cognitive behavioural therapy for the treatment of depression.
[read the full story...]Sarah McDonald reports on a meta-analysis published yesterday, which found that when compared with active treatment, mindfulness-based cognitive therapy resulted in a reduced risk of depressive relapse.
This blog also features a podcast interview with the lead author of the research, Professor Willem Kuyken.
[read the full story...]Sally Adams summarises a new BMJ systematic review and meta-analysis of working hours and alcohol use, which finds a link between longer working hours and risky alcohol consumption.
[read the full story...]Meta-analyses are an incredibly useful tool for synthesising evidence. However, such analyses typically use aggregate data, meaning the average scores or outcomes for treatment groups, which can cause problems if we’re trying to dig a little deeper into the question of ‘what works’ to answer ‘what works, and for whom?’ The ‘for whom?’ question is [read the full story…]